| Financial Year |
March 31 2023 |
| Monetary Funds |
3,662,022,307.62 |
| Held-for-trading Financial Assets |
464,292,830.68 |
| Notes Receivable |
48,320,308.45 |
| Accounts Receivable |
3,167,732,195.19 |
| Advances to Suppliers |
324,596,756.49 |
| Other Receivables |
81,079,341.39 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
5,013,720,596.73 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
4,000,000.00 |
| Other Current Assets |
242,713,629.01 |
| Total Current Assets |
13,046,835,592.74 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
467,881,231.71 |
| Investment Properties |
-- |
| Fixed Assetes |
15,123,809,568.44 |
| Under-construction Projects |
4,730,673,484.01 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
348,713,008.07 |
| R&D expenses |
-- |
| Goodwill |
1,064,173,384.50 |
| Long-Term Deferred and Prepaid Expenses |
13,844,921.30 |
| Deferred Income Tax Assets |
527,122,081.22 |
| Other Non-Current Assets |
545,022,402.92 |
| Sub-Total of Non-Current Assets |
22,938,848,816.42 |
| Total Assets |
35,985,684,409.16 |
| Short-Term Loans |
3,686,806,849.51 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
5,937,788,233.15 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
112,110,816.64 |
| Taxes Payable |
17,647,056.66 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
347,343,990.57 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,458,199,819.27 |
| Other Current Liabilities |
390,043,739.61 |
| Sub-Total of Current Liabilities |
13,483,995,589.36 |
| Long-term Loans |
6,943,528,575.52 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
177,361,182.18 |
| Other Non-Current Liabilities |
470,183,994.84 |
| Sub-Total of Non-Current Liabilities |
7,977,138,728.79 |
| Total Liabilities |
21,461,134,318.15 |
| Paid-In Capital(Or Share Stock) |
1,513,236,649.00 |
| Capital Surplus |
9,366,244,246.13 |
| Surplus Reserve |
259,317,048.64 |
| LESS:Treasury Stock |
35,651,155.90 |
| Undistributed Profits |
2,661,964,389.90 |
| Minority Stockholder's Interest |
739,138,222.30 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,785,411,868.71 |
| Owner's Equity（Stockholder's Equity） |
14,524,550,091.01 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
35,985,684,409.16 |
